Thu, May 16, 2024
Wed, May 15, 2024
Tue, May 14, 2024

Andrew Fein Reiterated (ABOS) at Strong Buy and Held Target at $15 on, May 15th, 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-15-on-may-15th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Andrew Fein of HC Wainwright & Co., Reiterated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $15 on, May 15th, 2024.

Andrew has made no other calls on ABOS in the last 4 months.



There is 1 other peer that has a rating on ABOS. Out of the 1 peers that are also analyzing ABOS, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $14 on, Sunday, March 31st, 2024